Hbk Sorce Advisory Lifted Position in Aflac (AFL) by $650,332; Dsm Capital Partners Stake in Abbott Laboratories (ABT) Has Cut as Shares Rose

Abbott Laboratories (NYSE:ABT) Logo

Dsm Capital Partners Llc decreased its stake in Abbott Laboratories (ABT) by 0.81% based on its latest 2018Q1 regulatory filing with the SEC. Dsm Capital Partners Llc sold 27,222 shares as the company’s stock rose 3.04% while stock markets declined. The hedge fund held 3.35M shares of the major pharmaceuticals company at the end of 2018Q1, valued at $200.58 million, down from 3.37 million at the end of the previous reported quarter. Dsm Capital Partners Llc who had been investing in Abbott Laboratories for a number of months, seems to be less bullish one the $108.82 billion market cap company. The stock increased 1.26% or $0.77 during the last trading session, reaching $62.07. About 5.95M shares traded. Abbott Laboratories (NYSE:ABT) has risen 41.91% since May 31, 2017 and is uptrending. It has outperformed by 29.34% the S&P500.

Hbk Sorce Advisory Llc increased its stake in Aflac Inc (AFL) by 97.64% based on its latest 2018Q1 regulatory filing with the SEC. Hbk Sorce Advisory Llc bought 15,124 shares as the company’s stock declined 0.09% with the market. The institutional investor held 30,614 shares of the accident &health insurance company at the end of 2018Q1, valued at $1.34 million, up from 15,490 at the end of the previous reported quarter. Hbk Sorce Advisory Llc who had been investing in Aflac Inc for a number of months, seems to be bullish on the $35.27B market cap company. The stock increased 2.22% or $0.99 during the last trading session, reaching $45.56. About 3.90 million shares traded or 4.55% up from the average. Aflac Incorporated (NYSE:AFL) has risen 21.38% since May 31, 2017 and is uptrending. It has outperformed by 8.81% the S&P500.

Among 22 analysts covering Aflac Incorporated (NYSE:AFL), 5 have Buy rating, 2 Sell and 15 Hold. Therefore 23% are positive. Aflac Incorporated had 60 analyst reports since August 12, 2015 according to SRatingsIntel. The rating was maintained by Wells Fargo on Thursday, July 27 with “Hold”. The firm earned “Hold” rating on Thursday, April 5 by Sandler O’Neill. The company was downgraded on Friday, September 8 by Bank of America. The firm has “Hold” rating given on Monday, May 23 by Sandler O’Neill. Citigroup maintained the shares of AFL in report on Thursday, February 4 with “Buy” rating. The company was maintained on Monday, December 5 by Deutsche Bank. The firm has “Market Perform” rating by FBR Capital given on Tuesday, May 10. The firm earned “” rating on Monday, October 12 by Keefe Bruyette & Woods. On Thursday, February 1 the stock rating was maintained by SunTrust with “Hold”. The stock of Aflac Incorporated (NYSE:AFL) earned “Sell” rating by RBC Capital Markets on Thursday, February 1.

Investors sentiment increased to 7.76 in 2018 Q1. Its up 6.70, from 1.06 in 2017Q4. It increased, as 56 investors sold AFL shares while 35 reduced holdings. 82 funds opened positions while 624 raised stakes. 1.00 billion shares or 291.45% more from 256.45 million shares in 2017Q4 were reported. Ubs Asset Mgmt Americas Incorporated invested in 0% or 3.74 million shares. 182,296 were accumulated by Chesapeake Asset Mngmt Ltd Liability Co. Fjarde Ap owns 0.15% invested in Aflac Incorporated (NYSE:AFL) for 217,602 shares. Walleye Trading Lc invested 0.01% in Aflac Incorporated (NYSE:AFL). Teachers Retirement Of The State Of Kentucky holds 0.04% in Aflac Incorporated (NYSE:AFL) or 83,400 shares. Raymond James And Assoc holds 1.28 million shares. Ellington Management Ltd Liability Corp has invested 0.02% in Aflac Incorporated (NYSE:AFL). Moreover, Hightower Advsr Ltd Liability Corporation has 0.03% invested in Aflac Incorporated (NYSE:AFL). New Jersey-based Palisade Mngmt Nj has invested 0.02% in Aflac Incorporated (NYSE:AFL). Matrix Asset Advsr Inc stated it has 0.05% of its portfolio in Aflac Incorporated (NYSE:AFL). Smith Howard Wealth Management Ltd holds 0.27% or 14,440 shares in its portfolio. Bnp Paribas Asset Mngmt Hldgs holds 0.03% or 80,007 shares in its portfolio. Conning stated it has 30,496 shares. Court Place Advisors Lc holds 1.16% in Aflac Incorporated (NYSE:AFL) or 63,500 shares. Polaris Greystone Fincl Group Limited Liability Corporation reported 366 shares stake.

Since February 16, 2018, it had 2 buys, and 4 sales for $2.81 million activity. Shares for $178,090 were bought by Lloyd Karole. $2.24 million worth of Aflac Incorporated (NYSE:AFL) was sold by AMOS DANIEL P. HOWARD JUNE P also sold $239,194 worth of Aflac Incorporated (NYSE:AFL) shares. $49,022 worth of Aflac Incorporated (NYSE:AFL) shares were bought by MOSKOWITZ JOSEPH L. $117,123 worth of Aflac Incorporated (NYSE:AFL) shares were sold by TILLMAN AUDREY B.

Another recent and important Aflac Incorporated (NYSE:AFL) news was published by Seekingalpha.com which published an article titled: “Aflac: Excellent Management Offers 50% Upside” on May 17, 2018.

Hbk Sorce Advisory Llc, which manages about $1.80 billion and $797.09M US Long portfolio, decreased its stake in General Mls Inc (NYSE:GIS) by 10,008 shares to 4,653 shares, valued at $210,000 in 2018Q1, according to the filing. It also reduced its holding in Boeing Co (NYSE:BA) by 962 shares in the quarter, leaving it with 8,993 shares, and cut its stake in Schwab Strategic Tr (SCHA).

Investors sentiment decreased to 0.83 in Q1 2018. Its down 0.08, from 0.91 in 2017Q4. It is negative, as 44 investors sold ABT shares while 606 reduced holdings. 126 funds opened positions while 411 raised stakes. 1.22 billion shares or 0.54% more from 1.22 billion shares in 2017Q4 were reported. Lipe And Dalton holds 2,000 shares. Finemark State Bank Tru stated it has 0.38% of its portfolio in Abbott Laboratories (NYSE:ABT). Schafer Cullen Mngmt invested 0.05% in Abbott Laboratories (NYSE:ABT). Family Firm holds 4,354 shares. Central National Bank & Trust & Company holds 0.12% of its portfolio in Abbott Laboratories (NYSE:ABT) for 8,230 shares. John G Ullman & Assoc holds 229,260 shares. Public Sector Pension Investment Board holds 119,277 shares or 0.05% of its portfolio. The New York-based First Manhattan Comm has invested 0.08% in Abbott Laboratories (NYSE:ABT). Automobile Association invested 0.22% of its portfolio in Abbott Laboratories (NYSE:ABT). Bancshares holds 0.12% in Abbott Laboratories (NYSE:ABT) or 7,173 shares. First Personal Ser holds 18,360 shares or 0.24% of its portfolio. 278,219 were accumulated by Creative Planning. Tarbox Family Office Inc owns 55,879 shares for 1.29% of their portfolio. Tdam Usa reported 0.55% stake. At Comml Bank reported 34,034 shares or 0.22% of all its holdings.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 107 analyst reports since July 24, 2015 according to SRatingsIntel. On Wednesday, June 21 the stock rating was reinitiated by BTIG Research with “Buy”. The firm earned “Buy” rating on Thursday, June 29 by Jefferies. On Friday, September 1 the stock rating was maintained by RBC Capital Markets with “Buy”. The rating was maintained by BMO Capital Markets with “Hold” on Thursday, August 31. The rating was upgraded by Barclays Capital on Wednesday, October 7 to “Overweight”. Morgan Stanley maintained it with “Equal-Weight” rating and $4 target in Tuesday, July 11 report. Stifel Nicolaus maintained Abbott Laboratories (NYSE:ABT) rating on Friday, September 22. Stifel Nicolaus has “Buy” rating and $58.0 target. The stock of Abbott Laboratories (NYSE:ABT) earned “Buy” rating by Gabelli on Friday, July 21. The rating was maintained by Stifel Nicolaus with “Buy” on Thursday, July 23. Citigroup maintained the shares of ABT in report on Thursday, October 19 with “Neutral” rating.

Since December 14, 2017, it had 1 insider buy, and 21 sales for $23.88 million activity. Bracken Sharon J also sold $62,056 worth of Abbott Laboratories (NYSE:ABT) on Wednesday, February 28. The insider Watkin Jared sold $183,579. Salvadori Daniel Gesua Sive had sold 28,319 shares worth $1.56M. Blaser Brian J sold $1.73M worth of stock. Funck Robert E sold $71,970 worth of stock or 1,220 shares. PEDERSON MICHAEL J sold $27,213 worth of stock.

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on July, 19. They expect $0.71 earnings per share, up 14.52% or $0.09 from last year’s $0.62 per share. ABT’s profit will be $1.24 billion for 21.86 P/E if the $0.71 EPS becomes a reality. After $0.59 actual earnings per share reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 20.34% EPS growth.

Another recent and important Abbott Laboratories (NYSE:ABT) news was published by Investorplace.com which published an article titled: “The 7 Best Long-Term Stocks for Risk-Off Investors” on May 29, 2018.

Dsm Capital Partners Llc, which manages about $5.78B and $7.25 billion US Long portfolio, upped its stake in Visa (NYSE:V) by 44,636 shares to 3.99M shares, valued at $477.28M in 2018Q1, according to the filing. It also increased its holding in Thermo Fisher Scientific (NYSE:TMO) by 508,763 shares in the quarter, for a total of 707,638 shares, and has risen its stake in Toronto (NYSE:TD).

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart